Harvard Bioscience (HBIO) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,340.00 |
| Dec 31, 2025 | -1,173.00 |
| Sep 30, 2025 | 38.00 |
| Jun 30, 2025 | -730.00 |
| Mar 31, 2025 | -21,451.00 |
| Dec 31, 2024 | 209.00 |
| Sep 30, 2024 | -1,069.00 |
| Jun 30, 2024 | -1,037.00 |
| Mar 31, 2024 | -1,193.00 |
| Dec 31, 2023 | -405.00 |
| Sep 30, 2023 | 96.00 |
| Jun 30, 2023 | -137.00 |
| Mar 31, 2023 | 2,363.00 |
| Dec 31, 2022 | -94.00 |
| Sep 30, 2022 | -1,387.00 |
| Jun 30, 2022 | 1,557.00 |
| Mar 31, 2022 | -2,024.00 |
| Dec 31, 2021 | 716.00 |
| Sep 30, 2021 | 367.00 |
| Jun 30, 2021 | 77.00 |
| Mar 31, 2021 | -89.00 |
| Dec 31, 2020 | -64.00 |
| Sep 30, 2020 | -163.00 |
| Jun 30, 2020 | -224.00 |
| Mar 31, 2020 | -1,192.00 |
| Dec 31, 2019 | -354.00 |
| Sep 30, 2019 | -1,351.00 |
| Jun 30, 2019 | -854.00 |
| Mar 31, 2019 | -1,030.00 |
| Dec 31, 2018 | 469.00 |
| Sep 30, 2018 | -339.00 |
| Jun 30, 2018 | -752.00 |
| Mar 31, 2018 | -2,432.00 |
| Dec 31, 2017 | -924.00 |
| Sep 30, 2017 | -729.00 |
| Jun 30, 2017 | -1,175.00 |
| Mar 31, 2017 | -1,007.00 |
| Dec 31, 2016 | -713.00 |
| Sep 30, 2016 | -307.00 |
| Jun 30, 2016 | -1,030.00 |
| Mar 31, 2016 | -801.00 |
| Dec 31, 2015 | 1,297.00 |
| Sep 30, 2015 | -1,017.00 |
| Jun 30, 2015 | -1,112.00 |